PRESS RELEASE published on 01/24/2025 at 07:00, 1 year 8 months ago BB Biotech: Preliminary full-year 2024 results and dividend proposal BB Biotech AG reports preliminary full-year 2024 results with a net profit of CHF 76 mn, proposing a dividend of CHF 1.80 per share at the AGM on March 19, 2025, focusing on shareholder returns and biotech sector growth Preliminary Results Dividend Proposal Biotech Sector Shareholder Returns BB Biotech
PRESS RELEASE published on 01/24/2025 at 07:00, 1 year 8 months ago EQS-Adhoc: BB Biotech AG closes the 2024 fiscal year with a profit BB Biotech AG closes the 2024 fiscal year with a profit of approximately CHF 76 million, reflecting share price development. Preliminary unaudited figures show a significant improvement from the previous year Investment Company Preliminary Figures BB Biotech AG Profit 2024 Fiscal Year
BRIEF published on 01/22/2025 at 14:36, 1 year 8 months ago Edison Highlights BB Biotech's Portfolio Boost Acquisition Net Asset Value Investment Biotech Sector BB Biotech
BRIEF published on 01/22/2025 at 14:36, 1 year 8 months ago Edison souligne l'augmentation du portefeuille de BB Biotech Acquisition Investissement Secteur Biotechnologique Valeur Nette D'inventaire Biotechnologie BB
PRESS RELEASE published on 01/22/2025 at 14:31, 1 year 8 months ago Edison issues report on BB Biotech (BION) Edison issues report on BB Biotech (BION) highlighting recent positive developments and implications for the biotech sector. Johnson & Johnson's acquisition of Intra-Cellular Therapies at a premium has boosted BB Biotech's net asset value Acquisition Edison Biotech Sector BB Biotech Johnson & Johnson
BRIEF published on 10/25/2024 at 07:05, 1 year 11 months ago BB Biotech AG Releases Interim Report with Positive Net Profit Investment Net Profit Biotech Sector Interim Report BB Biotech
BRIEF published on 10/25/2024 at 07:05, 1 year 11 months ago BB Biotech AG publie un rapport intermédiaire avec un bénéfice net positif Investissement Bénéfice Net Rapport Intérimaire Secteur Biotechnologique Biotechnologie BB
BRIEF published on 10/25/2024 at 07:05, 1 year 11 months ago BB Biotech: Strategic Portfolio Reallocation Amid Volatile Markets Financial Results Investment Strategy Biotech Sector BB Biotech Portfolio Reallocation
BRIEF published on 10/25/2024 at 07:05, 1 year 11 months ago BB Biotech : Réallocation stratégique du portefeuille dans un contexte de marchés volatils Résultats Financiers Stratégie D'investissement Secteur Biotechnologique Biotechnologie BB Réaffectation Du Portefeuille
PRESS RELEASE published on 10/25/2024 at 07:00, 1 year 11 months ago EQS-Adhoc: BB Biotech AG publishes its interim report BB Biotech AG publishes its interim report for the first nine months of 2024, showing a net profit and strategic investment details Investment Company Net Profit BB Biotech AG Interim Report Stocks
Published on 09/29/2026 at 02:30, 16 minutes ago QNX and neueHCT Join Forces to Accelerate Global Intelligent Driving Deployment, Anchored by Major German Automaker Program Win
Published on 09/29/2026 at 00:00, 2 hours 46 minutes ago Medicure Announces Completion of Enrollment in Its MEND-PNPO Phase 3 Clinical Trial
Published on 09/28/2026 at 23:00, 3 hours 46 minutes ago CORRECTION FROM SOURCE: Organto Foods Highlights Record First Half Results and Progress on Key Strategic Initiatives
Published on 09/28/2026 at 15:00, 11 hours 46 minutes ago Vox to Acquire Silver Royalty over the Sorby Hills Project in Australia
Published on 09/28/2026 at 14:45, 12 hours 1 minute ago Clinical Trial of the Oral Drug NV-387 to Treat Ebola Has Started Enrollment and Dosing of Patients Last Week (on or about September 23rd), Says NanoViricides
Published on 09/28/2026 at 22:14, 4 hours 32 minutes ago EQS-Adhoc: Extension of the Managing Directors' employment contracts of Carsten Cramer, Lars Ricken and Thomas Treß – Carsten Cramer appointed Chairman of the Management Board
Published on 09/28/2026 at 19:24, 7 hours 21 minutes ago EQS-Adhoc: Hapag-Lloyd further raises its earnings outlook for the current financial year
Published on 09/28/2026 at 19:00, 7 hours 46 minutes ago PATRIMOINE ET COMMERCE : Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 21 septembre 2026 au 25 septembre 2026
Published on 09/28/2026 at 18:00, 8 hours 46 minutes ago GEVELOT S.A.: Weekly declaration of share buybacks – 09/28/2026 (French only)
Published on 09/28/2026 at 18:00, 8 hours 46 minutes ago GEVELOT S.A.: Déclaration hebdomadaire de rachat d'actions 28/09/2026
Published on 09/28/2026 at 17:54, 8 hours 51 minutes ago Reporting on share buyback transactions carried out between September 21 and September 25, 2026
Published on 09/28/2026 at 17:54, 8 hours 51 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 21 et le 25 septembre 2026
Published on 09/28/2026 at 17:35, 9 hours 11 minutes ago Déclaration hebdomadaire d'opérations effectuées du 21 au 25 septembre 2026
